Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Pharmaceuticals (Basel, Switzerland)|November 20, 2020
Sustainability of Biosimilars in Europe: A Delphi Panel Consensus with Systematic Literature ReviewArnold G Vulto, Jackie Vanderpuye-Orgle, Martin van der Graaff, et al.
International Journal of Clinical Pharmacy|May 8, 2020
Use of amlodipine oral solution for the treatment of hypertension in childrenAnna C van der Vossen, Karlien Cransberg, Brenda C M de Winter, et al.
British Journal of Clinical Pharmacology|August 22, 2009
Variation in the CYP2D6 gene is associated with a lower serum sodium concentration in patients on antidepressantsSonja Kwadijk-de Gijsel, Monique J Bijl, Loes E Visser, et al.
Thrombosis and Haemostasis|November 13, 2002
Overanticoagulation associated with combined use of antibacterial drugs and acenocoumarol or phenprocoumon anticoagulantsLoes E Visser, Fernie J A Penning-van Bees, A A Harrie Kasbergen, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|January 4, 2024
Capturing the holistic value of biosimilars in Europe - part 1: a historical perspectiveJorge Mestre-Ferrandiz, Marcin Czech, Josef S Smolen, et al.
BMJ Open|December 22, 2016
Antithrombotic stewardship: a multidisciplinary team approach towards improving antithrombotic therapy outcomes during and after hospitalisation: a study protocolAlbert R Dreijer, Marieke J H A Kruip, Jeroen Diepstraten, et al.
Clinical Pharmacology and Therapeutics|June 28, 2002
Overanticoagulation associated with combined use of antifungal agents and coumarin anticoagulantsLoes E Visser, Fernie J A Penning-van Beest, A A Harrie Kasbergen, et al.
Pharmacogenetics and Genomics|July 21, 2009
Interpatient variability in IMPDH activity in MMF-treated renal transplant patients is correlated with IMPDH type II 3757T > C polymorphismFerdi Sombogaard, Ron H N van Schaik, Ron A Mathot, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|January 29, 2024
Leveraging the holistic benefits of biosimilars in Europe - part 2: how payers can safeguard the future of a healthy biosimilar market environmentJorge Mestre-Ferrandiz, Marcin Czech, Josef S Smolen, et al.
International Journal of Clinical Pharmacology and Therapeutics|November 13, 2015
Bioequivalence study of an extemporaneously prepared oral solution of amlodipine suitable for use in pediatric patients compared to commercial tabletsAnna C van der Vossen, Iris van der Velde, Anton H van den Meiracker, et al.
Pageof 12